GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Morepen Laboratories Ltd (NSE:MOREPENLAB) » Definitions » EV-to-FCF

Morepen Laboratories (NSE:MOREPENLAB) EV-to-FCF : (As of May. 14, 2024)


View and export this data going back to 1999. Start your Free Trial

What is Morepen Laboratories EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Morepen Laboratories's Enterprise Value is ₹23,342 Mil. Morepen Laboratories's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2023 was ₹0 Mil. Therefore, Morepen Laboratories's EV-to-FCF for today is .

The historical rank and industry rank for Morepen Laboratories's EV-to-FCF or its related term are showing as below:

NSE:MOREPENLAB' s EV-to-FCF Range Over the Past 10 Years
Min: -19.78   Med: 0   Max: 242.91
Current: -16.93

During the past 13 years, the highest EV-to-FCF of Morepen Laboratories was 242.91. The lowest was -19.78. And the median was 0.00.

NSE:MOREPENLAB's EV-to-FCF is ranked worse than
100% of 514 companies
in the Drug Manufacturers industry
Industry Median: 23.995 vs NSE:MOREPENLAB: -16.93

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-14), Morepen Laboratories's stock price is ₹46.40. Morepen Laboratories's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was ₹1.510. Therefore, Morepen Laboratories's PE Ratio for today is 30.73.


Morepen Laboratories EV-to-FCF Historical Data

The historical data trend for Morepen Laboratories's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Morepen Laboratories EV-to-FCF Chart

Morepen Laboratories Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
EV-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 140.58 -70.83 136.31 -13.72 -9.59

Morepen Laboratories Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - -9.59 - - -

Competitive Comparison of Morepen Laboratories's EV-to-FCF

For the Drug Manufacturers - Specialty & Generic subindustry, Morepen Laboratories's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Morepen Laboratories's EV-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Morepen Laboratories's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Morepen Laboratories's EV-to-FCF falls into.



Morepen Laboratories EV-to-FCF Calculation

Morepen Laboratories's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=23341.841/0
=

Morepen Laboratories's current Enterprise Value is ₹23,342 Mil.
Morepen Laboratories's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Morepen Laboratories  (NSE:MOREPENLAB) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Morepen Laboratories's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=46.40/1.510
=30.73

Morepen Laboratories's share price for today is ₹46.40.
Morepen Laboratories's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹1.510.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Morepen Laboratories EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Morepen Laboratories's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Morepen Laboratories (NSE:MOREPENLAB) Business Description

Traded in Other Exchanges
Address
2nd Floor, Tower C, DLF Cyber Park, Udyog Vihar-III, Sector 20, Gurugram, HR, IND, 122016
Morepen Laboratories Ltd is an India based pharmaceutical company. It develops, manufactures and markets generic drugs and pharmaceutical formulations. The company's products includes Tablets, Capsules, Injections, Ointments, Syrups, and Powders. It also offers products under brands Burnol, Lemolate and Fiber-X. The company's geographical markets include India, the United States and the rest of the world, with a majority of revenue being generated in India.

Morepen Laboratories (NSE:MOREPENLAB) Headlines

No Headlines